Intrinsic Value of S&P & Nasdaq Contact Us

Exscientia plc EXAI NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
34/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+3.3%

Financial Health Score — EXAI

Exscientia plc (EXAI) has an overall financial health rating of C- with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-11-18.

C-
Overall Rating
2024-11-18

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2024-11-18 C- -/5 -/5 -/5 -/5 -/5 -/5
2024-11-15 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-14 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-13 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-12 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-11 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-08 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-07 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-06 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-05 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-04 C -/5 -/5 -/5 -/5 -/5 -/5
2024-11-01 C -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message